Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


11.03.2024

1 AJR Am J Roentgenol
11 Am J Cardiol
1 Am J Crit Care
2 Angiology
1 Circ Cardiovasc Imaging
1 Circ Res
2 Circulation
1 Clin Cardiol
2 Clin Chem
6 Eur Heart J
8 Int J Cardiol
1 J Cardiovasc Pharmacol
3 J Mol Cell Cardiol
1 JAMA
3 Mayo Clin Proc
4 N Engl J Med
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. PARK C, Lee BC, Jeong WG, Park WJ, et al
    Coronary Artery Calcification on Low-Dose Lung Cancer Screening CT in South Korea: Visual and Artificial Intelligence-Based Assessment and Association With Cardiovascular Events.
    AJR Am J Roentgenol. 2024 Mar 6. doi: 10.2214/AJR.24.30852.
    PubMed         Abstract available


    Am J Cardiol

  2. JOLLY SS, Lee SF, Mian R, Kedev S, et al
    SYNERGY- Everolimus eluting stent with a bioabsorbable polymer in ST elevation myocardial infarction- CLEAR SYNERGY OASIS-9 Registry.
    Am J Cardiol. 2024 Mar 4:S0002-9149(24)00126.
    PubMed         Abstract available

  3. MORA FD, Portolan L, Terentes-Printzios D, Vicere A, et al
    Comprehensive Angiography-Derived Functional Assessment of Epicardial and Microvascular Coronary Disease, Correlation With Noninvasive Myocardial Stress Imaging.
    Am J Cardiol. 2024 Feb 29:S0002-9149(24)00108.
    PubMed         Abstract available

  4. ROBERTS CS, Hassan MH, Hasson L, Guileyardo JM, et al
    Fatal Acute Myocardial Infarction With Normal Epicardial Coronary Arteries Shortly Following COVID-19 Vaccination.
    Am J Cardiol. 2024 Feb 28:S0002-9149(24)00125.
    PubMed         Abstract available

  5. TARANTINI G, Fabris T, Banerjee S, Nai Fovino L, et al
    The "Fender" Technique for Redo-TAVR in a Degenerated Supra-Annular Valve With High Risk of Coronary Obstruction.
    Am J Cardiol. 2024;215:8-9.
    PubMed        

  6. LOZANO I, Suarez A, Rodriguez-Carrio J
    Coronary Ectasia and Antinuclear Antibodies: Another Clue to the Role of Immunology in Vascular Disease.
    Am J Cardiol. 2024;215:98.
    PubMed        

  7. ALTURKMANI H, Uretsky B, Patel S, Albadaineh M, et al
    Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00157.
    PubMed         Abstract available

  8. SINGH S, Garg A, Tantry US, Bliden K, et al
    Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00161.
    PubMed         Abstract available

  9. MUFARRIH SH, Haider S, Qureshi NQ, Khan MS, et al
    Distal Vs. Proximal Radial Arterial Access For Percutaneous Coronary Angiography and Intervention: Updated Meta-Analysis Of Randomized Controlled Trials.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00156.
    PubMed         Abstract available

  10. HAIDAR A, Srikanthan P, Watson K, Allison M, et al
    Associations between visceral fat, abdominal muscle, and coronary artery calcification: A cross-sectional analysis of the Multi-Ethnic Study of Atherosclerosis.
    Am J Cardiol. 2024 Mar 1:S0002-9149(24)00153.
    PubMed         Abstract available

  11. NDREPEPA G
    Percutaneous Coronary Intervention in Nonagenarians Presenting With an Acute Coronary Syndrome.
    Am J Cardiol. 2024 Feb 29:S0002-9149(24)00127.
    PubMed        

  12. BABAYIGIT E, Gorenek B
    Hybrid Coronary Revascularization: Has Everything Clearly Described?
    Am J Cardiol. 2024 Feb 28:S0002-9149(24)00130.
    PubMed        


    Am J Crit Care

  13. SACCO A, Pagnesi M, Frea S, Briani M, et al
    Transitioning to Palliative Care in an Italian Cardiac Intensive Care Unit Network.
    Am J Crit Care. 2024;33:145-148.
    PubMed         Abstract available


    Angiology

  14. OZBAY MB, Nriagu BN, Ozbay HS, Ozen Y, et al
    Letter: The Fibrosis-5 Index Predicts Major Adverse Cardiovascular Events.
    Angiology. 2024 Mar 6:33197241238397. doi: 10.1177/00033197241238397.
    PubMed        

  15. TOPRAK K, Kaplangoray M, Inanir M, Dursun A, et al
    Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction.
    Angiology. 2024 Mar 6:33197241238513. doi: 10.1177/00033197241238513.
    PubMed        


    Circ Cardiovasc Imaging

  16. KIRII Y, Kurita T, Morita K, Kasai Y, et al
    Unique Case of Coronary Artery Rupture and Acute Myocardial Infarction Triggered by a Karate Punch: Evaluation of the Hit Site by CT Imaging.
    Circ Cardiovasc Imaging. 2024 Mar 4:e016343. doi: 10.1161/CIRCIMAGING.123.016343
    PubMed        


    Circ Res

  17. MANZO OL, Nour J, Sasset L, Marino A, et al
    Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.
    Circ Res. 2024 Mar 8. doi: 10.1161/CIRCRESAHA.123.323826.
    PubMed         Abstract available


    Circulation

  18. RAJAGOPALAN S, Brook RD
    Cardiovascular and Planetary Health: Two Sides of the Same Planet.
    Circulation. 2024;149:729-731.
    PubMed        

  19. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
    The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
    Circulation. 2024;149:732-733.
    PubMed        


    Clin Cardiol

  20. KIM JH, Yoon YC, Kim YH, Park JI, et al
    Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus.
    Clin Cardiol. 2024;47:e24248.
    PubMed         Abstract available


    Clin Chem

  21. IVANOVA AA, Gardner MS, Kusovschi JD, Parks BA, et al
    Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk.
    Clin Chem. 2024;70:528-537.
    PubMed         Abstract available

  22. AAKRE KM, Apple FS, Mills NL, Meex SJR, et al
    Lower Limits for Reporting High-Sensitivity Cardiac Troponin Assays and Impact of Analytical Performance on Patient Misclassification.
    Clin Chem. 2024;70:497-505.
    PubMed         Abstract available


    Eur Heart J

  23. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    PubMed        

  24. CREA F
    Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
    Eur Heart J. 2024;45:637-641.
    PubMed        

  25. VERGALLO R, Galiuto L
    Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
    PubMed        

  26. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
    Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
    Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
    PubMed         Abstract available

  27. JANSEN TPJ, Wentzel JJ, Damman P
    Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
    Eur Heart J. 2024;45:737.
    PubMed        

  28. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    PubMed         Abstract available


    Int J Cardiol

  29. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    PubMed        

  30. ANDO G, Lombardo L, Alagna G, Micari A, et al
    Monotherapy with P2Y(12)-inhibitors after dual antiplatelet therapy: Filling gaps in evidence.
    Int J Cardiol. 2024;401:131893.
    PubMed         Abstract available

  31. GIACOBBE F, Giannino G, Annone U, Morena A, et al
    Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.
    Int J Cardiol. 2024 Mar 2:131933. doi: 10.1016/j.ijcard.2024.131933.
    PubMed         Abstract available

  32. BRUNO F, de Filippo O, Sardone A, Capranzano P, et al
    Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study.
    Int J Cardiol. 2024;401:131861.
    PubMed         Abstract available

  33. HAN D, Hyun MC, Miller RJH, Gransar H, et al
    10-year experience of utilizing a stress-first SPECT myocardial perfusion imaging.
    Int J Cardiol. 2024;401:131863.
    PubMed         Abstract available

  34. TANNER R, Farhan S, Giustino G, Sartori S, et al
    Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry.
    Int J Cardiol. 2024;401:131856.
    PubMed         Abstract available

  35. XIA B, Lu Y, Liang J, Li F, et al
    Association of GAL-8 promoter methylation levels with coronary plaque inflammation.
    Int J Cardiol. 2024;401:131782.
    PubMed         Abstract available

  36. RIEHLE C, Sieweke JT, Udesen NLJ, Helgestad OKL, et al
    Circulating biomarkers of the CS4P and CLIP scores are not altered in a pig model of acute cardiogenic shock and additional short-term circulatory support.
    Int J Cardiol. 2024;401:131699.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  37. MARTINEZ NAYA N, Toldo S, Abbate A
    Colchicine Leads the Charge in Post-percutaneous Coronary Intervention Anti-inflammatory Defense.
    J Cardiovasc Pharmacol. 2024;83:231-233.
    PubMed        


    J Mol Cell Cardiol

  38. CAO X, Thomas D, Whitcomb LA, Wang M, et al
    Modeling ionizing radiation-induced cardiovascular dysfunction with human iPSC-derived engineered heart tissues.
    J Mol Cell Cardiol. 2024;188:105-107.
    PubMed        

  39. NGUYEN T, Rosa-Garrido M, Sadek H, Garry DJ, et al
    Promoting cardiomyocyte proliferation for myocardial regeneration in large mammals.
    J Mol Cell Cardiol. 2024;188:52-60.
    PubMed         Abstract available

  40. DU C, Zhao S, Shan T, Han X, et al
    Cellular nucleic acid binding protein facilitates cardiac repair after myocardial infarction by activating beta-catenin signaling.
    J Mol Cell Cardiol. 2024;189:66-82.
    PubMed         Abstract available


    JAMA

  41. HARRIS E
    High Niacin Levels May Raise Cardiovascular Disease Risk.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1566.
    PubMed        


    Mayo Clin Proc

  42. SHARMA S, Johnson E, Goswami R
    Congenital Absence of Right Coronary Artery.
    Mayo Clin Proc. 2024 Mar 6:S0025-6196(23)00480.
    PubMed        

  43. MOSHKOVITZ Y, Orenstein L, Olmer L, Laufer K, et al
    Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery.
    Mayo Clin Proc. 2024 Mar 6:S0025-6196(23)00341.
    PubMed         Abstract available

  44. SOROOSH G, Dardari Z, Howard-Claudio C, Lutsey P, et al
    Older Adults' Perceptions of Their Risk and Its Correlation With Coronary Atherosclerosis Burden.
    Mayo Clin Proc. 2024;99:508-510.
    PubMed        


    N Engl J Med

  45. MARFELLA R, Prattichizzo F, Sardu C, Fulgenzi G, et al
    Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.
    N Engl J Med. 2024;390:900-910.
    PubMed         Abstract available

  46. CHAPALAIN X, Aubron C
    Transfusion Strategy in Myocardial Infarction and Anemia.
    N Engl J Med. 2024;390:960.
    PubMed        

  47. KHAN MS, Spertus JA, Chan PS
    Transfusion Strategy in Myocardial Infarction and Anemia.
    N Engl J Med. 2024;390:960-961.
    PubMed        

  48. CARSON JL, Brooks MM, Hebert PC
    Transfusion Strategy in Myocardial Infarction and Anemia. Reply.
    N Engl J Med. 2024;390:961-962.
    PubMed        


    PLoS One

  49. ALMEIDA JAB, Florencio RB, Leite JC, Monteiro KS, et al
    Self-efficacy measurement instruments for individuals with coronary artery disease: A systematic review.
    PLoS One. 2024;19:e0299041.
    PubMed         Abstract available

  50. PAN J, Ping PD, Wang W, Zhou JM, et al
    Cost-effectiveness analysis of Shexiang Baoxin Pill (MUSKARDIA) as the add-on treatment to standard therapy for stable coronary artery disease in China.
    PLoS One. 2024;19:e0299236.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.